{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:36:28Z","timestamp":1790876188111,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High-level Scientific Research Project of People\u2019s Hospital of Yangjiang","award":["G2021003"],"award-info":[{"award-number":["G2021003"]}]},{"name":"the State Key Project of Research and Development Plan","award":["2024YFE0106200"],"award-info":[{"award-number":["2024YFE0106200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s15010-025-02474-3","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T23:12:17Z","timestamp":1739574737000},"page":"1469-1481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of the in vitro activities and resistance mechanisms against imipenem\u2013relebactam and ceftazidime\u2013avibactam in clinical KPC-producing Klebsiella pneumoniae isolated in China"],"prefix":"10.1007","volume":"53","author":[{"given":"Yingyi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyue","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanhao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"Suppl 1","key":"2474_CR1","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","volume":"22","author":"FP Hu","year":"2016","unstructured":"Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014. Clin Microbiol Infect. 2016;22(Suppl 1):S9-14. https:\/\/doi.org\/10.1016\/j.cmi.2016.01.001.","journal-title":"Clin Microbiol Infect"},{"key":"2474_CR2","unstructured":"CHINETS. Chinet 2020 bacterial drug resistance monitoring results (full year). http:\/\/www.chinets.com\/Document. Accessed 22 Feb 2021."},{"issue":"1","key":"2474_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. https:\/\/doi.org\/10.1186\/s12941-017-0191-3.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"2474_CR4","doi-asserted-by":"publisher","first-page":"e01882","DOI":"10.1128\/AAC.01882-17","volume":"62","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE network. Antimicrob Agents Chemother. 2018;62(2):e01882-e1917. https:\/\/doi.org\/10.1128\/AAC.01882-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2474_CR5","doi-asserted-by":"publisher","first-page":"e02431","DOI":"10.1128\/AAC.02431-18","volume":"63","author":"D Yin","year":"2019","unstructured":"Yin D, Wu S, Yang Y, Shi Q, Dong D, Zhu D, et al. Results from the China antimicrobial surveillance network (CHINET) in 2017 of the in vitro activities of ceftazidime\u2013avibactam and ceftolozane-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2019;63(4):e02431-e2518. https:\/\/doi.org\/10.1128\/AAC.02431-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 4","key":"2474_CR6","doi-asserted-by":"publisher","first-page":"S427","DOI":"10.1093\/cid\/ciaa1519","volume":"71","author":"Q Yang","year":"2020","unstructured":"Yang Q, Zhang H, Yu Y, Kong H, Duan Q, Wang Y, et al. In vitro activity of imipenem\/relebactam against Enterobacteriaceae isolates obtained from intra-abdominal, respiratory tract, and urinary tract infections in China: study for monitoring antimicrobial resistance trends (SMART), 2015\u20132018. Clin Infect Dis. 2020;71(Suppl 4):S427\u201335. https:\/\/doi.org\/10.1093\/cid\/ciaa1519.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2474_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/420816","volume":"39","author":"DL Paterson","year":"2004","unstructured":"Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004;39(1):31\u20137. https:\/\/doi.org\/10.1086\/420816.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2474_CR8","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1128\/AAC.00633-16","volume":"60","author":"C Lucasti","year":"2016","unstructured":"Lucasti C, Vasile L, Sandesc D, Venskutonis D, McLeroth P, Lala M, et al. Phase 2, dose-ranging study of relebactam with imipenem-cilastatin in subjects with complicated intra-abdominal infection. Antimicrob Agents Chemother. 2016;60(10):6234\u201343. https:\/\/doi.org\/10.1128\/AAC.00633-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2474_CR9","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/jcm10051068","volume":"10","author":"E Yusuf","year":"2021","unstructured":"Yusuf E, Bax HI, Verkaik NJ, van Westreenen M. An update on eight \u201cnew\u201d antibiotics against multidrug-resistant gram-negative bacteria. J Clin Med. 2021;10(5):1068. https:\/\/doi.org\/10.3390\/jcm10051068.","journal-title":"J Clin Med"},{"issue":"6","key":"2474_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.18502\/ijm.v13i6.8080","volume":"13","author":"ME Mashaly","year":"2021","unstructured":"Mashaly ME, Mashaly GE. Activity of imipenem\/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility. Iran J Microbiol. 2021;13(6):785\u201392. https:\/\/doi.org\/10.18502\/ijm.v13i6.8080.","journal-title":"Iran J Microbiol"},{"issue":"1","key":"2474_CR11","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1080\/22221751.2021.1984182","volume":"10","author":"Y Guo","year":"2021","unstructured":"Guo Y, Liu N, Lin Z, Ba X, Zhuo C, Li F, et al. Mutations in porin LamB contribute to ceftazidime\u2013avibactam resistance in KPC-producing Klebsiella pneumoniae. Emerg Microbes Infect. 2021;10(1):2042\u201351. https:\/\/doi.org\/10.1080\/22221751.2021.1984182.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"2474_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/antibiotics11050628","volume":"11","author":"P Gaibani","year":"2022","unstructured":"Gaibani P, Giani T, Bovo F, Lombardo D, Amadesi S, Lazzarotto T, et al. Resistance to ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam in gram-negative MDR Bacilli: molecular mechanisms and susceptibility testing. Antibiotics (Basel). 2022;11(5):628. https:\/\/doi.org\/10.3390\/antibiotics11050628.","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"2474_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00918-22","volume":"66","author":"J Findlay","year":"2022","unstructured":"Findlay J, Rens C, Poirel L, Nordmann P. In vitro mechanisms of resistance development to imipenem\u2013relebactam in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2022;66(10): e0091822. https:\/\/doi.org\/10.1128\/aac.00918-22.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2474_CR14","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1128\/JCM.01924-13","volume":"51","author":"S Brisse","year":"2013","unstructured":"Brisse S, Passet V, Haugaard AB, Babosan A, Kassis-Chikhani N, Struve C, et al. wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol. 2013;51(12):4073\u20138. https:\/\/doi.org\/10.1128\/JCM.01924-13.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2474_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/1471-2105-11-595","volume":"10","author":"KA Jolley","year":"2010","unstructured":"Jolley KA, Maiden MC. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinform. 2010;10(11):595. https:\/\/doi.org\/10.1186\/1471-2105-11-595.","journal-title":"BMC Bioinform"},{"key":"2474_CR16","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Thirty-one informational supplement. 31th ed; 2021. pp. M100S."},{"key":"2474_CR17","unstructured":"The Food and Drug Administration. Tigecycline\u2013injection products [EB\/OL]. 2023. https:\/\/www.fda.gov\/drugs\/development-resources\/tigecycline-injection-products. Accessed 8 Apr 2023."},{"issue":"12","key":"2474_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/myc.12665","volume":"60","author":"FA Silva","year":"2017","unstructured":"Silva FA, Conde-Felipe M, Rosario I, Ferrer O, Real F, D\u00e9niz S, et al. Susceptibility of Malassezia pachydermatis to aminoglycosides. Mycoses. 2017;60(12):796\u20139. https:\/\/doi.org\/10.1111\/myc.12665.","journal-title":"Mycoses"},{"issue":"2","key":"2474_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1089\/fpd.2019.2701","volume":"17","author":"V Trinetta","year":"2020","unstructured":"Trinetta V, Magossi G, Allard MW, Tallent SM, Brown EW, Lomonaco S. Characterization of Salmonella enterica isolates from selected U.S. swine feed mills by whole-genome sequencing. Foodborne Pathog Dis. 2020;17(2):126\u201336. https:\/\/doi.org\/10.1089\/fpd.2019.2701.","journal-title":"Foodborne Pathog Dis"},{"issue":"14","key":"2474_CR20","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","volume":"30","author":"T Seemann","year":"2014","unstructured":"Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btu153.","journal-title":"Bioinformatics"},{"key":"2474_CR21","unstructured":"Seeimann T. Mlst Github. https:\/\/github.com\/tseemann\/mlst. Accessed 22 Feb 2021."},{"issue":"9","key":"2474_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/antibiotics13090807","volume":"13","author":"L Yao","year":"2024","unstructured":"Yao L, Liu N, Guo Y, Zhuo C, Yang X, Wang Y, et al. Comparison of hypervirulent and non-hypervirulent carbapenem-resistant Acinetobacter baumannii isolated from bloodstream infections: mortality, potential virulence factors, and combination therapy in vitro. Antibiotics (Basel). 2024;13(9):807. https:\/\/doi.org\/10.3390\/antibiotics13090807.","journal-title":"Antibiotics (Basel)"},{"issue":"8","key":"2474_CR23","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10121","volume":"27","author":"IB Olawoye","year":"2020","unstructured":"Olawoye IB, Frost SDW, Happi CT. The bacteria genome pipeline (BAGEP): an automated, scalable workflow for bacteria genomes with Snakemake. PeerJ. 2020;27(8): e10121. https:\/\/doi.org\/10.7717\/peerj.10121.","journal-title":"PeerJ"},{"issue":"1","key":"2474_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12866-021-02293-0","volume":"21","author":"L Sun","year":"2021","unstructured":"Sun L, Li H, Wang Q, Liu Y, Cao B. Increased gene expression and copy number of mutated blaKPC lead to high-level ceftazidime\/avibactam resistance in Klebsiella pneumoniae. BMC Microbiol. 2021;21(1):230. https:\/\/doi.org\/10.1186\/s12866-021-02293-0.","journal-title":"BMC Microbiol"},{"issue":"7","key":"2474_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2105-7-85","volume":"22","author":"JS Yuan","year":"2006","unstructured":"Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real-time PCR data. BMC Bioinform. 2006;22(7):85. https:\/\/doi.org\/10.1186\/1471-2105-7-85.","journal-title":"BMC Bioinform"},{"issue":"3","key":"2474_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105903","volume":"55","author":"S Naha","year":"2020","unstructured":"Naha S, Sands K, Mukherjee S, Roy C, Rameez MJ, Saha B, et al. KPC-2-producing Klebsiella pneumoniae ST147 in a neonatal unit: clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump. Int J Antimicrob Agents. 2020;55(3): 105903. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105903.","journal-title":"Int J Antimicrob Agents"},{"issue":"23","key":"2474_CR27","doi-asserted-by":"publisher","first-page":"e01834","DOI":"10.1128\/AEM.01834-18","volume":"84","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang S, Chen W, Song L, Zhang Y, Shen Z, et al. CRISPR-Cas9 and CRISPR-assisted cytidine deaminase enable precise and efficient genome editing in Klebsiella pneumoniae. Appl Environ Microbiol. 2018;84(23):e01834-e1918. https:\/\/doi.org\/10.1128\/AEM.01834-18.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"2474_CR28","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1038\/s41467-024-49349-z","volume":"15","author":"M Budia-Silva","year":"2024","unstructured":"Budia-Silva M, Kostyanev T, Ayala-Monta\u00f1o S, Bravo-Ferrer Acosta J, Garcia-Castillo M, Cant\u00f3n R, et al. International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe. Nat Commun. 2024;15(1):5092. https:\/\/doi.org\/10.1038\/s41467-024-49349-z.","journal-title":"Nat Commun"},{"key":"2474_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jgar.2020.09.004","volume":"23","author":"W Liao","year":"2020","unstructured":"Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174\u201380. https:\/\/doi.org\/10.1016\/j.jgar.2020.09.004.","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"2474_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41564-024-01612-1","volume":"9","author":"F Hu","year":"2024","unstructured":"Hu F, Pan Y, Li H, Han R, Liu X, Ma R, et al. Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-centre study. Nat Microbiol. 2024;9(3):814\u201329. https:\/\/doi.org\/10.1038\/s41564-024-01612-1.","journal-title":"Nat Microbiol"},{"issue":"3","key":"2474_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/antibiotics13030285","volume":"13","author":"S Ferous","year":"2024","unstructured":"Ferous S, Anastassopoulou C, Pitiriga V, Vrioni G, Tsakris A. Antimicrobial and diagnostic stewardship of the novel \u03b2-lactam\/\u03b2-lactamase inhibitors for infections due to carbapenem-resistant Enterobacterales Species and Pseudomonas aeruginosa. Antibiotics (Basel). 2024;13(3):285. https:\/\/doi.org\/10.3390\/antibiotics13030285.","journal-title":"Antibiotics (Basel)"},{"key":"2474_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jgar.2019.11.007","volume":"22","author":"\u00c1 Cano","year":"2020","unstructured":"Cano \u00c1, Guzm\u00e1n-Puche J, Garc\u00eda-Guti\u00e9rrez M, Cast\u00f3n JJ, Gracia-Ahufinger I, P\u00e9rez-Nadales E, et al. Use of carbapenems in the combined treatment of emerging ceftazidime\/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: report of a case and review of the literature. J Glob Antimicrob Resist. 2020;22:9\u201312. https:\/\/doi.org\/10.1016\/j.jgar.2019.11.007.","journal-title":"J Glob Antimicrob Resist"},{"issue":"9","key":"2474_CR33","doi-asserted-by":"publisher","first-page":"e00776","DOI":"10.1128\/JCM.00776-18","volume":"56","author":"TA Russo","year":"2018","unstructured":"Russo TA, Olson R, Fang CT, Stoesser N, Miller M, MacDonald U, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. 2018;56(9):e00776-e818. https:\/\/doi.org\/10.1128\/JCM.00776-18.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2474_CR34","doi-asserted-by":"publisher","first-page":"e01206","DOI":"10.1128\/JCM.01206-19","volume":"57","author":"S Harada","year":"2019","unstructured":"Harada S, Aoki K, Yamamoto S, Ishii Y, Sekiya N, Kurai H, et al. Clinical and molecular characteristics of Klebsiella pneumoniae isolates causing bloodstream infections in Japan: occurrence of hypervirulent infections in health care. J Clin Microbiol. 2019;57(11):e01206-e1219. https:\/\/doi.org\/10.1128\/JCM.01206-19.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2474_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02414-21","volume":"66","author":"TA Alsenani","year":"2022","unstructured":"Alsenani TA, Viviani SL, Kumar V, Taracila MA, Bethel CR, Barnes MD, et al. Structural characterization of the D179N and D179Y variants of KPC-2 \u03b2-lactamase: \u03a9-loop destabilization as a mechanism of resistance to ceftazidime\u2013avibactam. Antimicrob Agents Chemother. 2022;66(4): e0241421. https:\/\/doi.org\/10.1128\/aac.02414-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2474_CR36","doi-asserted-by":"publisher","first-page":"124.e1","DOI":"10.1016\/j.cmi.2019.08.020","volume":"26","author":"P Zhang","year":"2020","unstructured":"Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, et al. Emergence of ceftazidime\/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect. 2020;26(1):124.e1-124.e4. https:\/\/doi.org\/10.1016\/j.cmi.2019.08.020.","journal-title":"Clin Microbiol Infect"},{"key":"2474_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jgar.2021.04.001","volume":"25","author":"S Di Bella","year":"2021","unstructured":"Di Bella S, Giacobbe DR, Maraolo AE, Viaggi V, Luzzati R, Bassetti M, et al. Resistance to ceftazidime\/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies. J Glob Antimicrob Resist. 2021;25:268\u201381. https:\/\/doi.org\/10.1016\/j.jgar.2021.04.001.","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"2474_CR38","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jac\/dkab496","volume":"77","author":"MA Gomis-Font","year":"2022","unstructured":"Gomis-Font MA, Cabot G, L\u00f3pez-Arg\u00fcello S, Zamorano L, Juan C, Moy\u00e1 B, et al. Comparative analysis of in vitro dynamics and mechanisms of ceftolozane\/tazobactam and imipenem\/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones. J Antimicrob Chemother. 2022;77(4):957\u201368. https:\/\/doi.org\/10.1093\/jac\/dkab496.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2474_CR39","doi-asserted-by":"publisher","first-page":"e02408","DOI":"10.1128\/AAC.02408-19","volume":"64","author":"BD Johnston","year":"2020","unstructured":"Johnston BD, Thuras P, Porter SB, Anacker M, VonBank B, Vagnone PS, et al. Activity of imipenem\u2013relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, coresistance, and region. Antimicrob Agents Chemother. 2020;64(5):e02408-e2419. https:\/\/doi.org\/10.1128\/AAC.02408-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"38","key":"2474_CR40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203593119","volume":"119","author":"JLC Wong","year":"2022","unstructured":"Wong JLC, David S, Sanchez-Garrido J, Woo JZ, Low WW, Morecchiato F, et al. Recurrent emergence of Klebsiella pneumoniae carbapenem resistance mediated by an inhibitory OmpK36 mRNA secondary structure. Proc Natl Acad Sci U S A. 2022;119(38): e2203593119. https:\/\/doi.org\/10.1073\/pnas.2203593119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2474_CR41","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fmicb.2020.01365","volume":"23","author":"X Cui","year":"2020","unstructured":"Cui X, Shan B, Zhang X, Qu F, Jia W, Huang B, et al. Reduced ceftazidime\u2013avibactam susceptibility in KPC-producing Klebsiella pneumoniae from patients without ceftazidime\u2013avibactam use history - a multicenter study in China. Front Microbiol. 2020;23(11):1365. https:\/\/doi.org\/10.3389\/fmicb.2020.01365.","journal-title":"Front Microbiol"},{"issue":"7","key":"2474_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1089\/mdr.2018.0065","volume":"24","author":"G Balabanian","year":"2018","unstructured":"Balabanian G, Rose M, Manning N, Landman D, Quale J. Effect of porins and blaKPC expression on activity of imipenem with relebactam in Klebsiella pneumoniae: can antibiotic combinations overcome resistance? Microb Drug Resist. 2018;24(7):877\u201381. https:\/\/doi.org\/10.1089\/mdr.2018.0065.","journal-title":"Microb Drug Resist"},{"issue":"8","key":"2474_CR43","doi-asserted-by":"publisher","first-page":"e00389","DOI":"10.1128\/AAC.00389-17","volume":"61","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Kashikar A, Brown CA, Denys G, Bush K. Unusual Escherichia coli PBP 3 insertion sequence identified from a collection of carbapenem-resistant Enterobacteriaceae tested in vitro with a combination of ceftazidime-, ceftaroline-, or aztreonam-avibactam. Antimicrob Agents Chemother. 2017;61(8):e00389-e417. https:\/\/doi.org\/10.1128\/AAC.00389-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2474_CR44","doi-asserted-by":"publisher","first-page":"e0078721","DOI":"10.1128\/mSystems.00787-21","volume":"6","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Chen J, Shen H, Chen Z, Yang QW, Zhu J, et al. Emergence of ceftazidime- and avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Pseudomonas aeruginosa in China. mSystems. 2021;6(6):e0078721. https:\/\/doi.org\/10.1128\/mSystems.00787-21.","journal-title":"mSystems"},{"issue":"13","key":"2474_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/IDR.S233808","volume":"30","author":"NA Hassuna","year":"2020","unstructured":"Hassuna NA, Darwish MK, Sayed M, Ibrahem RA. Molecular epidemiology and mechanisms of high-level resistance to meropenem and imipenem in Pseudomonas aeruginosa. Infect Drug Resist. 2020;30(13):285\u201393. https:\/\/doi.org\/10.2147\/IDR.S233808.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"2474_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1571","volume":"14","author":"L Xiong","year":"2022","unstructured":"Xiong L, Wang X, Wang Y, Yu W, Zhou Y, Chi X, et al. Molecular mechanisms underlying bacterial resistance to ceftazidime\/avibactam. WIREs Mech Dis. 2022;14(6): e1571. https:\/\/doi.org\/10.1002\/wsbm.1571.","journal-title":"WIREs Mech Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02474-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02474-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02474-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:05:02Z","timestamp":1754352302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02474-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2474"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02474-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}